1. Miller D R, Leikin S, Albo Y, Sather H, Hammond D: Prognostic importance of morphology (FAB classification) in childhood, acute lymphoblastic leukemia (ALL),Br J Haemat
48, 199 (1981).
2. Mathé G, Rappaport H, O’Conor G T, Torloni H: Histological and cytological typing of neoplastic diseases of haematopoietic and lymphoid tissues. Geneva, World Health Organization (1976).
3. Minowada J, Sagawa K, Lok M S, Kubonishi I, Nakazawa S, Tatsumi E, Ohnuma T, Goldblum N: A model of lymphoid cell differentiation based on the study of marker profiles of 50 human leukemia-lymphoma cell lines, in Serrou B, Rosenfeld C (ed):International Symposium on New Trends in Human Immunology and Cancer Immunotherapy, p. 188. Paris, Doin publisher (1980).
4. Bernard A, Boumsell L, Reinherz E L, Nadler L M, Ritz J, Coppin H, Richard Y, Valensi F, Dausset J, Flandrin G, Lemerle J, Schlossman S F: Cell surface characterization of malignant T-cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T-cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma.Blood
57, 1105 (1981).
5. Nadler L M, Ritz J, Reinherz E L, Schlossman S T: Cellular origins of human leukemias and lymphomas, in Knapp W (ed).Leukemic Cell Markers, p. 3. New York, Academic Press (1982).